Shilpa Medicare · NSE: SHILPAMED · BSE: 530549

Q1 FY20 results · Apr–Jun 2019

Shilpa Medicare reported revenue from operations of ₹160.99 crore (down 18.8% from Q1 FY19) and net profit of ₹14.96 crore (down 55.5% from Q1 FY19) for Q1 FY20 (Apr–Jun 2019), on a consolidated basis.

Consolidated · ₹ crore
Item	Q1 FY20	Q1 FY19	YoY	Q4 FY19	QoQ
Revenue from operations	160.99	198.17	−18.8%	199.52	−19.3%
Other income	1.98	4.36	−54.5%	3.09	−35.9%
Total income	162.97	202.52	−19.5%	202.61	−19.6%
Profit before share of associates & JVs and tax	18.66	48.24	−61.3%	28.09	−33.6%
Share of profit/(loss) of associates & JVs	0.35	(4.97)		0.49
Net profit for the period	14.96	33.64	−55.5%	22.98	−34.9%
Attributable to shareholders of the company	15.74	33.64	−53.2%	23.88	−34.1%
EPS, basic (₹)	1.93	4.13	−53.3%	2.93	−34.1%
Net margin (%)	9.3	17.0		11.5

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
Item	Q1 FY20	Q1 FY19	YoY	Q4 FY19	QoQ
Revenue from operations	154.58	180.18	−14.2%	171.02	−9.6%
Other income	3.46	3.96	−12.7%	3.56	−2.9%
Total income	158.03	184.14	−14.2%	174.58	−9.5%
Profit before tax	31.70	51.90	−38.9%	23.87	+32.8%
Net profit for the period	26.10	42.71	−38.9%	16.70	+56.3%
EPS, basic (₹)	3.20	5.24	−38.9%	2.05	+56.1%
Net margin (%)	16.9	23.7		9.8

Consolidated

Filed with BSE: 16 Aug 2019, 16:09 IST
Board meeting: 13 Aug 2019
Period: 01 Apr 2019 to 30 Jun 2019
Review status: Unaudited
Source: XBRL filing on BSE

Standalone

Filed with BSE: 16 Aug 2019, 16:09 IST
Board meeting: 13 Aug 2019
Period: 01 Apr 2019 to 30 Jun 2019
Review status: Unaudited
Source: XBRL filing on BSE